Original Article

You have full text access to this OnlineOpen article

Diabetes and risk of bladder cancer

Evidence from a case-control study in New England

  1. Todd MacKenzie PhD1,2,†,*,
  2. Michael S. Zens PhD2,
  3. Assiamira Ferrara MD, PhD3,
  4. Alan Schned MD4,
  5. Margaret R. Karagas PhD2

Article first published online: 8 NOV 2010

DOI: 10.1002/cncr.25641

Issue

Cancer

Cancer

Volume 117, Issue 7, pages 1552–1556, 1 April 2011

Additional Information

How to Cite

MacKenzie, T., Zens, M. S., Ferrara, A., Schned, A. and Karagas, M. R. (2011), Diabetes and risk of bladder cancer. Cancer, 117: 1552–1556. doi: 10.1002/cncr.25641

Author Information

  1. 1

    Department of Medicine, Dartmouth Medical School, Hanover, New Hampshire

  2. 2

    Department of Community and Family Medicine, Dartmouth Medical School, Hanover, New Hampshire

  3. 3

    Division of Research, Kaiser Permanente Northern California, Oakland, California

  4. 4

    Department of Pathology, Dartmouth Medical School, Hanover, New Hampshire

  1. †

    Fax: (603) 653-3542

*Section of Clinical Research, Dartmouth Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH 03756

Publication History

  1. Issue published online: 18 MAR 2011
  2. Article first published online: 8 NOV 2010
  3. Manuscript Accepted: 22 JUN 2010
  4. Manuscript Revised: 10 JUN 2010
  5. Manuscript Received: 22 MAR 2010

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (117K)

REFERENCES

  • 1
    Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2007. Atlanta, GA: Centers for Disease Control and Prevention, US Dept of Health and Human Services; 2008.
  • 2
    Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R. Diabetes and cancer. Endocr Relat Cancer. 2009; 16: 1103-1123.
  • 3
    Grote VA, Becker S, Kaaks R. Diabetes mellitus type 2—an independent risk factor for cancer? Exp Clin Endocrinol Diabetes. 2010; 118: 4-8.
  • 4
    Batty GD, Shipley MJ, Marmot M, Smith GD. Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study. Cancer Causes Control. 2004; 15: 873-881.
  • 5
    Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med. 2006; 166: 1871-1877.
  • 6
    U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999-2006 Incidence and Mortality. 2010; Available at: http://apps.nccd.cdc.gov/uscs/ Accessed June 2010.
  • 7
    Adami HO, Hunter DJ, and Trichopoulos D. Textbook of Cancer Epidemiology. Monographs in Epidemiology and Biostatistics. New York, NY: Oxford University Press; 2002.
  • 8
    Larsson SC, Orsini N, Brismar K, Wolk A. Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia. 2006; 49: 2819-2823.
  • 9
    Chen SL, Jackson SL, Boyko EJ. Diabetes mellitus and urinary tract infection: epidemiology, pathogenesis and proposed studies in animal models. J Urol. 2009; 182( 6 Suppl): S51-6.
  • 10
    Kantor AF, Hartge P, Hoover RN, Narayana AS, Sullivan JW, Fraumeni JF Jr. Urinary tract infection and risk of bladder cancer. Am J Epidemiol; 1984; 119: 510-515.
  • 11
    Jiang X, Castelao JE, Groshen S, et al. Urinary tract infections and reduced risk of bladder cancer in Los Angeles. Br J Cancer. 2009; 100: 834-839.
  • 12
    Fortuny J, Kogevinas M, Zens MS, et al. Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study. BMC Urol 2007; 7: 13.
  • 13
    Havener L, Standards for Cancer Registries, Vol III: Standards for Completeness, Quality, Analysis, and Management of Data. Springfield, IL: North American Association of Central Cancer Registries, 2008.
  • 14
    (2010) Registry Certification Available at: http://www.naaccr. org/ Accessed June 2010.
  • 15
    Little RJA, Rubin DB. Statistical Analysis With Missing Data, 2nd ed. Hoboken, NJ: Wiley, 2002.
  • 16
    Larsson SC, Andersson SO, Johansson JE, Wolk A. Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men. Eur J Cancer. 2008; 44: 2655-2660.
  • 17
    Lifford KL, Curhan GC, Hu FB, Barbieri RL, Grodstein F. Type 2 diabetes mellitus and risk of developing urinary incontinence. J Am Geriatr Soc. 2005; 53: 1851-1857.
    Direct Link:
  • 18
    Koebnick C, Michaud D, Moore SC, et al. Body mass index, physical activity, and bladder cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev. 2008; 17: 1214-1221.
  • 19
    Vigneri R. Diabetes: diabetes therapy and cancer risk. Nat Rev Endocrinol. 2009; 5: 651-652.
  • 20
    Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 2005; 293: 194-202.
  • 21
    Rapp K, Schroeder J, Klenk J, et al. Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia. 2006; 49: 945-952.
  • 22
    Lubet RA, Fischer SM, Steele VE, Juliana MM, Desmond R, Grubbs CJ Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers. Int J Cancer. 2008; 123: 2254-2259.
    Direct Link:
  • 23
    Ramos-Nino ME, MacLean CD, Littenberg B. Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System. BMC Med. 2007; 5: 17.
  • 24
    National Diabetes Data Group of the National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes in America. 2nd ed. Bethesda, MDNational Institutes of Health; 1995.
  • 25
    Margolis KL, Lihong Qi, Brzyski R, et al. Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements. Clin Trials, 2008. 5:3 p. 240-7.
  • 26
    Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol. 2004; 57: 1096-1103.
View Full Article (HTML) Get PDF (117K)